Evaluation of a Living With Hope Program

This study has been completed.
Sponsor:
Information provided by:
University of Saskatchewan
ClinicalTrials.gov Identifier:
NCT00161317
First received: September 8, 2005
Last updated: September 7, 2006
Last verified: September 2006
  Purpose

The Living with Hope program was developed by the research team, a panel of experts and palliative patients and their families. The program was evaluated with 60 advanced cancer patients 60 years of age and older. Thirty received the program and 30 did not. After one week, those receiving the Living with Hope Program had higher hope and quality of life scores compared to those who did not. This suggests that the program is effective in increasing hope and quality of life for older palliative care patients with cancer.


Condition Intervention
Cancer
Behavioral: Living with Hope Program

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Development, Implementation and Evaluation of a Psychosocial Supportive Hope Focused Program for Patients With Advanced Cancer

Resource links provided by NLM:


Further study details as provided by University of Saskatchewan:

Primary Outcome Measures:
  • Hope (Herth Hope Index) and Quality of Life (MacGill Quality of Life Questionnaire.

Estimated Enrollment: 60
Study Start Date: December 2003
Estimated Study Completion Date: February 2006
Detailed Description:

The overall purpose of this study was to evaluate the effectiveness of a psychosocial supportive intervention called “Living with Hope Program” (LWHP) in increasing hope and quality of life for older adult community-living terminally ill cancer patients. Using a mixed method concurrent nested experimental design, 60 terminally ill cancer patients over the age of 60 years were randomly assigned to a treatment and control group. Baseline hope [Herth Hope Index (HHI)] and quality of life scores [McGill Quality of Life Questionnaire, (MQOL)] were collected at the first visit in the patients’ homes by trained research assistants. Those in the treatment group received the LWHP, which consisted of viewing an international award winning video on hope and a choice of one of three hope activities to work on over a one-week period. The control group received standard care. Hope and quality of life data were collected one week later from both groups. Qualitative data using open-ended hope questions were collected from the treatment group.

Subjects receiving the Living with Hope Program had statistically significant higher hope (U=255, p=.005) and quality of life scores at visit two (U=294.5, p=.027) than those in the control group. Qualitative data confirmed this finding with the majority (61.5%) of subjects in the treatment group reporting the LWHP increased their hope. This preliminary evaluation of the effectiveness of the LWHP suggests that it may increase hope and quality of life for older terminally ill cancer patients at home.

  Eligibility

Ages Eligible for Study:   60 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Inclusion criteria for the study is; a) male or female 60 years of age and over, b) diagnosed with cancer, c) receiving palliative home care services d) English speaking, e) able to give informed consent and participate in the study as determined by the Palliative Care Coordinator or SWADD team’s assessment.

Exclusion Criteria:

Exclusion criteria includes patients who are non-autonomous adults, cognitively impaired as determined by the SWADD team and or unable in the opinion of the SWADD team to participate-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00161317

Sponsors and Collaborators
University of Saskatchewan
Investigators
Principal Investigator: Wendy Duggleby University of Saskatchewan
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00161317     History of Changes
Other Study ID Numbers: BSC 03-899
Study First Received: September 8, 2005
Last Updated: September 7, 2006
Health Authority: Canada: Health Canada

ClinicalTrials.gov processed this record on April 15, 2014